Search clinical trials for: Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers
Total 473825 results
-
AstraZenecaCompletedCYP2C19 Poor | Extensive MetabolizersTaiwan
-
PfizerMedivation, Inc.CompletedAlzheimer's Disease | Huntington's DiseaseUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPoor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantBrazil
-
University of Southern DenmarkCompleted
-
Beijing Anzhen HospitalUnknownAntiplatelet Therapy | CYP2C19 PolymorphismChina
-
Stanford UniversityRecruiting
-
Central Hospital, Nancy, FranceMinistry of Health, France; University Hospital of Saint-Etienne; Grand Est RegionCompletedThrombosis | Deep Vein Thrombosis | COVID | Pulmonary EmbolismFrance
-
University of South DakotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedMetabolic Syndrome | HypertriglyceridemiaUnited States
-
Gyeongsang National University HospitalCompletedMyocardial InfarctionKorea, Republic of
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompleted
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Duke UniversityActive, not recruitingDepression | Chronic Pain | Acute PainUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Duke UniversityNational Human Genome Research Institute (NHGRI)Active, not recruitingAcute PainUnited States
-
Jason Lang, M.D., M.P.H.Nemours Children's Clinic; Thrasher Research FundActive, not recruitingGenotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma (GenARA)Asthma | Gastroesophageal RefluxUnited States
-
Duke UniversityNational Human Genome Research Institute (NHGRI)Active, not recruitingDepressionUnited States
-
Indiana UniversitySponsor Name PendingCompleted
-
Asan Medical CenterUnknown
-
University Hospital Bispebjerg and FrederiksbergCompletedAlcohol WithdrawalDenmark
-
University of WashingtonNational Institute of General Medical Sciences (NIGMS)CompletedHealthy Volunteers | Drug-Drug Interaction
-
University of Southern DenmarkOdense University HospitalTerminatedCytochrome P450 Phenotype and Genotype MetricsDenmark
-
Xinjiang Medical UniversityCompletedCoronary Artery Disease
-
Javeriana UniversityUniversidad Nacional de ColombiaCompletedTherapy | H.Pylori Infection | CYP2C19 Polymorphism
-
Seoul National University HospitalCompletedHealthy VolunteersKorea, Republic of
-
St. Antonius HospitalRecruitingCoronary Artery Disease | Platelet ReactivityNetherlands
-
Duke UniversityNational Human Genome Research Institute (NHGRI)Active, not recruitingChronic PainUnited States
-
Children's Mercy Hospital Kansas CityCompletedObesity | GERDUnited States
-
University of FloridaCompletedObsessive Compulsive Disorder | Anxiety | Major Depressive DisorderUnited States
-
National Taiwan University HospitalCompleted
-
Medco Health Solutions, Inc.TerminatedCardiovascular DiseaseUnited States
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
Scripps HealthBristol-Myers Squibb; Sanofi; Accumetrics, Inc.Completed
-
Medical University of BialystokNational Science Centre, PolandCompletedEffects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal BleedingNon-variceal Upper Gastrointestinal BleedingPoland
-
National Institute of Allergy and Infectious Diseases...Completed
-
Chinese PLA General HospitalUnknown
-
Inje UniversityCompleted
-
University of Southern DenmarkH. Lundbeck A/SCompleted
-
Spartan Bioscience Inc.Mount Sinai ServicesCompleted
-
UCB Biopharma S.P.R.L.CompletedHealthy Japanese ParticipantsJapan
-
Boehringer IngelheimCompleted
-
Gyeongsang National University HospitalUnknownCoronary Artery Stenosis | Maximal Platelet Aggregation | Late Platelet Aggregation | High Post-Treatment Platelet ReactivityKorea, Republic of
-
University of MonastirCompletedSchizophrenia | Clozapine | CYP1A2 Polymorphism | CYP2C19 PolymorphismTunisia
-
Spartan Bioscience Inc.The Ottawa Hospital; Children's Hospital of Eastern Ontario; The University of...Completed
-
Spartan Bioscience Inc.Ottawa Hospital Research Institute; Children's Hospital of Eastern Ontario; Mount...Completed
-
National Health Research Institutes, TaiwanChang Gung Memorial Hospital; National Science Council, Taiwan; Taipei Medical... and other collaboratorsUnknown
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Chinese PLA General HospitalUnknownCLOPIDOGREL, POOR METABOLISM of (Disorder)China
-
Mayo ClinicNot yet recruitingSide Effect of Drug | Pharmacogenomic Drug Interaction | Drug Metabolism, Poor, CYP2D6-Related | Ineffective Drug Action | Drug Metabolism, Poor, CYP2C19-RelatedUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
St. Antonius HospitalRecruitingAcute Coronary Syndrome | CYP2C19 PolymorphismNetherlands